FENOFIBRATE RAN fenofibrate 145mg film coated tablets bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

fenofibrate, Quantity: 145 mg

Available from:

Sun Pharma ANZ Pty Ltd

INN (International Name):

Fenofibrate

Pharmaceutical form:

Tablet

Composition:

Excipient Ingredients: microcrystalline cellulose; silicon dioxide; pregelatinised maize starch; sucrose; sodium lauryl sulfate; hypromellose; crospovidone; sodium stearylfumarate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin

Administration route:

Oral

Units in package:

30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Fenofibrate is indicated as an adjunct to diet in the treatment of: - hypercholesterolaemia; - types II, III, IV and V dyslipidaemia; - dyslipidaemia associated with type 2 diabetes.

Product summary:

Visual Identification: White to off-white, oval shaped, biconvex film coated tablets debossed with 'RH 38' on one side and other side plain; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Licence status A

Authorization date:

2016-02-29